Bessemer Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Sell |
355
-135
| -28% | -$3.04K | ﹤0.01% | 1877 |
|
|
2025
Q1 | $8K | Buy |
+490
| New | +$8K | ﹤0.01% | 1837 |
|
|
2024
Q4 | – | Sell |
-75
| Closed | -$1K | – | 2433 |
|
|
2024
Q3 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 2308 |
|
|
2022
Q2 | – | Sell |
-191
| Closed | -$5K | – | 1857 |
|
|
2022
Q1 | $5K | Hold |
191
| – | – | ﹤0.01% | 1498 |
|
|
2021
Q4 | $4K | Hold |
191
| – | – | ﹤0.01% | 1613 |
|
|
2021
Q3 | $3K | Hold |
191
| – | – | ﹤0.01% | 1565 |
|
|
2021
Q2 | $5K | Hold |
191
| – | – | ﹤0.01% | 1422 |
|
|
2021
Q1 | $5K | Buy |
+191
| New | +$5K | ﹤0.01% | 1386 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1455 |
|
|
2017
Q1 | – | Sell |
-117
| Closed | -$3K | – | 1731 |
|
|
2016
Q4 | $3K | Buy |
+117
| New | +$3K | ﹤0.01% | 1797 |
|
|
2015
Q4 | – | Sell |
-10
| Closed | – | – | 1562 |
|
|
2015
Q3 | $0 | Buy |
+10
| New | – | ﹤0.01% | 1614 |
|